Long-Term Stability of Anti-Vascular Endothelial Growth Factor (a-VEGF) Biologics Under Physiologically Relevant Conditions and Its Impact on the Development of Long-Acting Delivery Systems-Reference-Cited by-同舟云学术

Long-Term Stability of Anti-Vascular Endothelial Growth Factor (a-VEGF) Biologics Under Physiologically Relevant Conditions and Its Impact on the Development of Long-Acting Delivery Systems

Published:2021-02 Issue:2 Volume:110 Page:860-870
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Chang Debby P.,Burra Shalini,Day Eric S.,Chan Joyce,Comps-Agrar Laetitia,Nivaggioli Thierry,Rajagopal Karthikan

Funder

Genentech

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference49 articles.

1. How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review;Taylor;BMJ Open,2016

2. Mechanisms of age-related macular degeneration;Ambati;Neuron,2012

3. Age-related macular degeneration;Coleman;Lancet,2008

4. A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration;Park;Int Ophthalmol,2017

5. The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy;Pozarowska;Cent Eur J Immunol,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of Receptor Binding Affinity for Vascular Endothelial Growth Factor with Interferometric Imaging Sensor;Biosensors;2024-06-24

2. Long-Acting Strategies for Antibody Drugs: Structural Modification, Controlling Release, and Changing the Administration Route;European Journal of Drug Metabolism and Pharmacokinetics;2024-04-18

3. Stability of ranibizumab during continuous delivery from the Port Delivery Platform;Journal of Controlled Release;2024-02

4. Clinical Trials and Future Outlooks of the Port Delivery System with Ranibizumab: A Narrative Review;Ophthalmology and Therapy;2023-12-06

5. Long‐Acting Microparticle Formulation of Griseofulvin for Ocular Neovascularization Therapy;Small;2023-11-08